May 6, 2014

The Food and Drug Administration's Nonprescription Drugs Advisory Committee on Friday voted 11-4 opposed to switching Merck's allergy remedy Singulair from Rx-to-OTC, according to an Associated Press report.

May 6, 2014

Greer Labs announced the launch and commmercial availability of Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablets.

May 6, 2014

Last winter's flu season was fairly typical of other winters over the last decade, with the prevalence of the flu and the number of people who had flu shots both fairly close to the averages for that time period, the Harris Poll reported Tuesday.

May 6, 2014

Pfizer's Nexium 24HR will launch May 27, Pfizer reported in a conference call Monday.

May 6, 2014

In a study released Saturday that included data from more than 3 million children and adolescents from diverse geographic regions of the United States, researchers found that the prevalence of both Type 1 and Type 2 diabetes increased significantly between 2001 and 2009.

May 5, 2014

The Generic Pharmaceutical Association on Monday hired Felecia Tan for the role of AVP sciences and regulatory affairs.

May 5, 2014

Kmart Pharmacy has announced that it is working with Diplomat Specialty Pharmacy to give Kmart customers and Shop Your Way members access to specialty medications.

May 5, 2014

Teva Pharmaceutical Industries on Monday announced that the Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) for injection, to include home administration.

May 5, 2014

Target has announced that two Brunet Target affiliated pharmacies are now open at the Brossard and Sainte-Dorothée Target store locations.

May 5, 2014

The World Health Organization on Monday released a statement concerning the international spread of poliovirus.

May 2, 2014

AstraZeneca rejected Pfizer's $106 billion bid for the company Friday morning.

May 2, 2014

Bayer is negotiating for Merck's consumer health business in a deal worth $14 billion, according to a Bloomberg report published Friday, citing people with knowledge of the matter.

May 2, 2014

The Consumer Healthcare Products Association on Wednesday commended Arizona Governor Jan Brewer for signing H.B. 2086 in to law.

May 2, 2014

An average of $3.9 billion per year in avoidable healthcare utilization costs would be realized if all U.S. adults older than 55 years diagnosed with age-related eye disease were to use lutein and zeaxanthin dietary supplements at preventive intake levels, according to a new economic report released Thursday by the Council for Responsible Nutrition.

May 2, 2014

MyFitnessPal on Thursday published its first user data study, uncovering a new trend in which people share health-related goals, activities and personal health content with their friends, colleagues and relatives, online and off.

May 2, 2014

Seattle Mayor Ed Murray on Thursday unveiled a plan to increase the city’s minimum wage to $15. Although Murray said the hike has broad support across local government, business and labor communities, the City Council still has to vote on the proposal.

May 1, 2014

GlaxoSmithKline on Wednesday announced that the Food and Drug Administration approved Incruse Ellipta (umeclidinium), which is used for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and/or emphysema.

May 1, 2014

An effort to raise the federal minimum wage to $10.10 failed on Wednesday, as the issue was not able to clear a procedural vote in the Senate.

May 1, 2014

LeapFrog Enterprises, which specializes in educational entertainment for children, on Thursday announced the introduction of LeapBand, the first wearable activity tracker designed for kids that encourages active play and healthy habits.

May 1, 2014

Purdue Pharma on Wednesday announced that it filed a new drug application with the Food and Drug Administration to market a hydrocodone bitartrate tablet, which is formulated to incorporate abuse-deterrent technology.

May 1, 2014

For the first time since the Great Recession, births are trending upwards in 2014, according to the April edition of the U.S. Fertility Forecast from Demographic Intelligence.

April 30, 2014

The Food and Drug Administration on Tuesday granted approval to Zykadia (ceritinib) for patients with a specific type of late-stage (metastatic) non-small cell lung cancer (NSCLC).

April 30, 2014

Empowering its customers with new ways to manage their health, MobileHelp — a provider of mobile Personal Emergency Response System solutions — has launched a new medication reminder application.

April 29, 2014

Jubilant Life Sciences, an integrated pharmaceuticals and life sciences company, last week announced that it received approval from the Food and Drug Administration for spironolactone tablets, 25 mg, 50 mg and 100 mg, which is the generic version of Aldactone.